Sign In
Buy ARC
$3.39
+0 (+0%)
At Close: Feb 20, 2025
ARC Resources: Earnings Are On Track
08:54pm, Sunday, 09'th Nov 2025
ARC Resources is launching the first phase of the Attachie Project. A disappointing Attachie well pad and dry gas production shut-ins impacted reported growth. AETUF's year-to-date earnings are on tra
Beam Middle East to Introduce EV ARC™ and BeamBike™ at DRIFTx in Abu Dhabi
06:00am, Tuesday, 04'th Nov 2025
Beam Middle East will debut the EV ARC™ and BeamBike™ solar-powered charging systems at DRIFTx in Abu Dhabi, advancing clean mobility in the region.
ARC Resources Ltd. (TSE:ARX) Receives Consensus Rating of “Buy” from Brokerages
01:42am, Friday, 24'th Oct 2025
ARC Resources Ltd. (TSE: ARX - Get Free Report) has been given an average recommendation of "Buy" by the seven analysts that are currently covering the company, MarketBeat reports. Seven analysts have
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
01:30am, Monday, 13'th Oct 2025
EINDHOVEN, the Netherlands, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, func
ARC Group Invests in ScanTech AI Systems, Backing Company's AI-Powered Security and Regulatory Alignment
08:00am, Friday, 10'th Oct 2025
Atlanta, GA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a developer of advanced AI-powered security screening and imaging systems, to
EINDHOVEN, The Netherlands, Sept. 18, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, fu
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
02:44am, Monday, 08'th Sep 2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
12:30pm, Monday, 18'th Aug 2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
Arc Resources: Look Beyond 2028 At This Undervalued Cannibal
12:36pm, Friday, 15'th Aug 2025
ARC Resources is quietly compounding value through production growth, margin expansion from LNG-linked pricing, and a shift toward more liquids in its production mix. The recent Kakwa acquisition stre
LONDON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced it was named i
Hana RFID Introduces The ‘Brava', an Ultra-Compact (42x16) ARC-Certified Inlay equipped with Impinj M830 chip
10:53am, Friday, 01'st Aug 2025
SOLON, Ohio, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Hana Technologies, Inc. (Hana RFID), a global leader in RAIN RFID inlay and embeddable tag design and manufacturing, proudly unveils its latest inlay mod
ARC Resources: An Extra Production Jump From An Acquisition
08:42am, Tuesday, 29'th Jul 2025
ARC Resources closed a highly accretive Kakwa acquisition. Management's opportunistic deal-making and strong execution are underappreciated assets. The Attachie production startup and the Kakwa deal w
Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC
08:00am, Tuesday, 01'st Jul 2025
PETACH TIKVA, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a clinical and ed
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
01:30am, Tuesday, 01'st Jul 2025
EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, fu
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
01:30am, Tuesday, 17'th Jun 2025
EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, fu
